Yamamoto S, Teng W, Nishizawa S, Kakiuchi T, Tsukada H
Department of Neurosurgery, Hamamatsu University School of Medicine, Japan.
J Neurosurg. 2000 Jun;92(6):1009-15. doi: 10.3171/jns.2000.92.6.1009.
The hydroxyl radical scavenger (+/-)-N,N'-propylenedinicotinamide (AVS) has been shown to ameliorate the occurrence of vasospasm following experimental subarachnoid hemorrhage (SAH) and to reduce the incidence of delayed ischemic neurological deficits (DINDs) in patients with SAH. The authors investigated whether prophylactic administration of AVS could improve cerebral blood flow (CBF) and cerebral glucose utilization (CGU) following SAH in rats.
Anesthetized rats were subjected to intracisternal injection of blood (SAH group) or saline (control group). Either AVS (1 mg/kg/min) or saline (vehicle group) was continuously injected into the rat femoral vein. Forty-eight hours later, positron emission tomography scanning was used with the tracers 15O-H2O and 18F-2-fluoro-D-glucose to analyze quantitatively CBF and CGU, respectively, in the frontoparietal and occipital regions (12 regions of interest/group). In SAH rats receiving only vehicle, CBF decreased significantly (p < 0.05, Tukey's test) and CGU tended to decrease, compared with values obtained in control (non-SAH) rats receiving vehicle. In rats that were subjected to SAH, administration of AVS significantly (p < 0.05, Tukey's test) improved CBF and CGU in both the frontoparietal and occipital regions compared with administration of vehicle alone.
Prophylactic administration of AVS improves CBF and CGU in the rat brain subjected to SAH, and can be a good pharmacological treatment for the prevention of DINDs following SAH.
已证实羟自由基清除剂(±)-N,N'-亚丙基二烟酰胺(AVS)可改善实验性蛛网膜下腔出血(SAH)后血管痉挛的发生,并降低SAH患者延迟性缺血性神经功能缺损(DINDs)的发生率。作者研究了预防性给予AVS是否能改善大鼠SAH后的脑血流量(CBF)和脑葡萄糖利用率(CGU)。
将麻醉的大鼠进行脑池内注射血液(SAH组)或生理盐水(对照组)。将AVS(1mg/kg/min)或生理盐水(载体组)持续注入大鼠股静脉。48小时后,使用示踪剂15O-H2O和18F-2-氟-D-葡萄糖进行正电子发射断层扫描,分别定量分析额顶叶和枕叶区域(每组12个感兴趣区域)的CBF和CGU。与接受载体的对照(非SAH)大鼠相比,仅接受载体的SAH大鼠的CBF显著降低(p<0.05,Tukey检验),CGU有降低趋势。在接受SAH的大鼠中,与单独给予载体相比,给予AVS显著(p<0.05,Tukey检验)改善了额顶叶和枕叶区域的CBF和CGU。
预防性给予AVS可改善SAH大鼠脑内的CBF和CGU,并且可能是预防SAH后DINDs的良好药物治疗方法。